Agility will be the focus for Pharmaceutical and Medical Device Markets in 2016, says AMPLEXOR Life Sciences
The newly branded technology and services group warns that current market pressures demand a more holistic approach to global data handling.
Until the life sciences industry treats content management holistically, its ability to seize new market opportunities may be limited. So says Mark Evenepoel, group CEO of AMPLEXOR — the newly branded 360-degree content management corporation which brings together four technology and services powerhouses: euroscript, INFOTEHNA, ForeignExchange Translations, and Amplexor.
The combined group, rebranded as AMPLEXOR, will incorporate the AMPLEXOR Life Sciences brand as of today, and specializes in helping life sciences organizations accelerate their speed to market and enter new countries quickly. Its solutions and services expedite the creation and delivery of consistent, compliant and high-quality global content — both physical and digital — across all of a company’s target markets.
“Without a consistent, holistic approach to all forms of content, life sciences companies will never be truly agile,” Evenepoel warns. “The industry knows that, and I believe 2016 will be a turning point.”
His comments chime with research published by Gens & Associates (Next Generation Content Management “Pulse Survey”) in April. This suggests that life sciences organizations which manage their content at a holistic, pan-enterprise level derive greater value from their investments. All companies surveyed expect to move towards an enterprise-wide approach to content management governance within the next 2-5 years, as they strive to create a global authoritative source of content and information sharing.
Employing 1,600 people in 24 countries across four continents, AMPLEXOR Life Sciences has a 30+ year history of serving the biggest names in the pharmaceutical, medical device and biotechnology markets. It combines euroscript, a leading life sciences content management implementation specialist; INFOTEHNA, with its powerful content management platform and leading suite of life sciences solutions; ForeignExchange Translations, which provides expert professional medical translation, and Amplexor, a digital experience platform for managing content across web, mobile and social channels.
With its comprehensive technology solutions and professional services, spanning all forms of physical and digital content, AMPLEXOR Life Sciences is a leading, visionary one-stop-shop partner for life sciences companies. Its services include technology consultancy, implementation and management services; technical writing & linguistic services, and marketing asset creation and management.
“We’re very excited about the year ahead,” says Evenepoel, who before the rebranding was CEO of euroscript. “Pharma, medical device manufacturers and biotech firms face some significant challenges in 2016 as they align themselves with the latest regulatory reporting requirements while simultaneously racing competitors to bring out new products and enter new markets.
“There is so much going on for the sector right now. What we’re offering them is a lasting solution to one of the core challenges: managing all of the content and keeping it compliant and consistent wherever it appears ─ and ready to go as soon as it’s needed.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance